Champions Oncology Investor Relations Material
Latest events
Q1 2026
Champions Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Champions Oncology Inc
Access all reports
Champions Oncology, Inc. is a technology-driven research organization that provides preclinical and clinical solutions to support drug development in the pharmaceutical and biotechnology industries. The company specializes in oncology-focused services, including patient-derived xenograft (PDX) models, biomarker discovery, and data analytics. The company is headquartered in Hackensack, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CSBR
Country
🇺🇸 United States